U.S. Eyes New Stock Rules

Federal securities regulators are moving toward easing decades-old constraints on share issues by private companies, in a sweeping review that could remake the way American start-ups raise capital.

Warning: Oversharing Ahead, as Wall Street Bankers Start to Talk Up Web 2.0 IPOs

Goldman Sachs seems to have borked the $1.5 billion deal to sell Facebook shares to its rich U.S. clients, because so much information about it leaked everywhere. That’s right! The loquacious Wall Street bankers are back to take Web 2.0′s social stars public and, of course, are oversharing already.

Seventh Person Arrested in Insider Trading Probe

Another arrest of an expert consultant in the ever-widening FBI investigation into insider trading of tech companies.

Sirius: We’ll Just Put This Delisting Notice in the Circular File

It was inevitable, really. Having given up the gains that pushed its shares past $1 and failed to close over that threshold for 10 straight days by March 15, Sirius XM invited a delisting notice. And Wednesday afternoon Nasdaq gave it one.

Mac Quicken Gets Deductions for Iffy Upgrade

Intuit’s upgrade of Mac Quicken keeps its promises, but is no match for the Windows version—and a step backward in some features on the 2007 Mac version.

Former Intel General Counsel Now Apple General Counsel

Longtime Intel general counsel Bruce Sewell, who left the company without explanation yesterday, evidently had good reason for doing so: He has taken a new job at Apple. That would certainly explain the “surprise” Intel expressed over his departure. And also why the company was so quick to remove his corporate bio from its Web site.
sewell_aapl

The Two Sides of Verizon's Deal Making

Verizon Communications Inc. boss Ivan Seidenberg may be one of the best deal makers of his time, or one of the worst. Today, three of Verizon’s most significant divestitures are either in bankruptcy or near it. As they say on Wall Street, it all depends on what side of the trade you’re on.

SEC Won't Let Steve Be

What happened between Apple’s January 5 disclosure of Steve Jobs’s “hormonal imbalance” and the company’s January 14 announcement that the CEO would be taking a six-month leave of absence? That’s the focus of an ongoing Securities and Exchange Commission probe into Steve Jobs’s health, an investigation that seems to, well, be going nowhere.
stevewtf

SEC Won’t Let Steve Be

What happened between Apple’s January 5 disclosure of Steve Jobs’s “hormonal imbalance” and the company’s January 14 announcement that the CEO would be taking a six-month leave of absence? That’s the focus of an ongoing Securities and Exchange Commission probe into Steve Jobs’s health, an investigation that seems to, well, be going nowhere.
stevewtf

Broadcom Makes Hostile $9.25/Shr Bid For Emulex

Broadcom this morning announced an unsolicited $9.25 a share cash offer to acquire Emulex. The deal has a total value of $764 million. The offer is 40 percent above yesterday’s closing price for ELX at $6.61.